Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SRE heads into its November 4 earnings report with a familiar tension: a constructive analyst consensus that has spent six weeks cutting its price targets, met by a stock that has quietly recovered 3% this week to $82.37.
The Street's direction of travel is unambiguous, but the message is nuanced. Bulge-bracket names remain broadly positive on Sempra: JP Morgan and Barclays both kept Overweight ratings this week while trimming targets, to $99 and $90 respectively, and Truist cut its Buy target modestly to $94. Morgan Stanley did the same in September. The pattern across all five firms is the same: conviction on the name, but valuation expectations drifting lower. The mean price target now stands at $98.19, implying roughly 19% upside from the current price. That gap is wide enough to keep the bulls interested, though it has been narrowing steadily. Jefferies bucked the trend in September with an upgrade to Buy, and Scotiabank initiated at Sector Perform with an $83 target, barely above where the stock is trading now. The bull case centres on Sempra's 80% ownership of Oncor and its infrastructure franchise; the bear case points to wildfire liability exposure, LNG project risk, and a parent balance sheet weighed down by rising interest costs. On forward earnings, the picture looks more encouraging: the 12-month forward EPS growth rank clears the 83rd percentile, and the analyst recommendation dispersion factor scores in the 91st percentile, meaning the Street is more uniformly positive on Sempra than on most peers. EV/EBITDA has drifted up about a full turn over the past 30 days to 16.2x, while the P/E has been broadly flat at around 15x.
Positioning tells a more cautious story beneath the surface. Short interest has climbed 13% over the past week to roughly 1.97% of free float, and is up about 15% over the past month. Those absolute levels are low, so this is not a structurally shorted name. But the direction is worth noting: someone has been adding to the short book consistently through October, even as the stock has bounced. Borrow conditions give shorts no reason to worry about a squeeze. Availability is extraordinarily loose, with roughly 79 shares available to borrow for every one currently lent out, a ratio well above the 52-week tightest level and essentially at the permissive end of the range. Cost to borrow has edged up about 17% over the past month but remains negligible at 0.43%, confirming that adding short exposure here carries almost no carry cost. Options tell a different story from the shorts: the put/call ratio has been sliding over the past month and now runs slightly below its 20-day average at 0.71, about half a standard deviation light on defensive positioning. That divergence, shorts quietly building while options traders appear less hedged than usual, is the most interesting tension in the positioning picture this week.
On the ownership side, the register is dominated by index-adjacent holders. BlackRock and Vanguard entities together account for over 22% of shares outstanding, with State Street adding another 5.8%. Wellington Management is the largest active holder with 6.7% of shares and added nearly two million shares in the quarter to August. Capital International Investors, by contrast, cut its stake from 7.8% to 3.0% in a significant reduction reported in May. All 13D/G filings are passive 13G, and no activist has registered an intent to push for change. Insider activity has been negligible in the 90-day window, with the most recent disclosed trades being routine officer sales in June.
Alt data adds one note of interest. EPA data covering Sempra's power generation operations recorded its smallest June gross capacity factor since 2024, coming in at 3.87%. The dataset has not been measured to lead the company's reported financials, so this is colour rather than a forward signal. Retail attention, measured via Wikipedia traffic against Sempra's own 90-day history, was running modestly above trend in late September, though that reading predates the recent round of analyst activity.
With earnings on November 4, the next three weeks turn on whether the target-cutting cycle from the Street has priced in the operational headwinds, or whether the print surfaces new pressure on the infrastructure segment that analysts have not yet fully reflected.
See the live data behind this article on ORTEX.
Open SRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
